Published in Bioterrorism Week, January 15th, 2007
The article, titled "Do We Have The Medicines To Fight Terrorism'" reviews the current absence of treatments able to address bioterror threats and discusses the Aethlon Hemopurifier as a potential first-line countermeasure able to treat drug and vaccine resistant pathogens, including those genetically modified for increased virulence.
The article also discusses the role of Aethlon in the shift towards broad-spectrum therapeutics, and the potential of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.